East Hills, NY (Oct. 15, 2007) -- Experts called on government and medical organizations involved in blood transfusion to “reverse one of the most serious public health policy errors in the history of ...
Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, today announced the launch of the Leukotrap® Affinity Plus Prion and Leukocyte Reduction Filter System. The ...
SAN DIEGO, CA / ACCESSWIRE / May 23, 2022 / Plandai Biotechnology Inc. (OTC PINK:PLPL) (the "Company") today announced its entry into a non-binding letter of intent to enter into a new business ...
PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, today announced the launch of the Leukotrap® Affinity Plus Prion and ...
The Food and Drug Administration issued a safety advisory on Haemonetics’ Leukotrap RC System, warning that faulty filters in some of the recently distributed devices can result in high leukocyte ...
No reactions were reported after LeukoNet filters were withdrawn from the market. Conclusions. This transfusion‐associated red eye syndrome was linked to a specific brand of leukocyte‐reduction filter ...
Many countries have implemented universal leukocyte depletion (LD) of blood components, whereas in others leukocyte-depleted components may be issued for selected patient groups only. In the UK, a ...
Over the last decade, more than 1000 cases of successful human umbilical cord blood transplantation have been reported. This has established the utility of using umbilical cord blood as an alternative ...
SAN DIEGO, CA / ACCESSWIRE / May 23, 2022 / Plandai Biotechnology Inc. (OTC PINK:PLPL) (the "Company") today announced its entry into a non-binding letter of intent to enter into a new business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback